Introduction {#s001}
============

The incidence rates of anal cancer have been increasing in the United States significantly over the past two decades. The relative risk (RR) for anal cancer in men aged 20--34 years was four times as high as to women of the same age between 1997 and 2009.^[@B1],[@B2]^ The average annual percentage change in this same age group was 10.7% in men, which was more than double the rate in women at 4.0%. Similarly, the RR for anal cancer in men 35--49 years was almost two and a half times higher that of women. The reason for this disproportionate incidence of anal cancer in these age groups is not well understood in the literature. The unequal incidence is not seen in older patients. These reports demonstrate that young men have emerged as the most vulnerable demographic subgroup at risk for developing anal cancer.

Prior research suggests that the increased incidence seen in the young male population is due to changing sexual practices.^[@B1]^ Approximately 85% of the anal cancer cases are squamous cell carcinoma of the anus (SCCA): a disease believed to be etiologically associated with human papillomavirus (HPV) infection. The risk factors for contraction of HPV include lifetime number of sexual partners, sexual practices, race, age, same-sex sexual behavior, and underlying human immunodeficiency virus (HIV) infection. Thus, among the highest risk for development of anal cancer are HIV positive men who have sex with men (MSM), showing a RR of 59.5.^[@B3]^ Although many individuals who are infected with HPV spontaneously clear the virus without showing any symptoms, those infected with HIV are at increased risk of persistent HPV infection and, therefore, at increased risk for anal cancer.^[@B4]^ The most recent report by the CDC stated an HIV incidence rate of 44.3 (per 100,000) for African Americans compared with 5.3 for Caucasians. Furthermore, 70% of new infections were attributed to male-to-male sexual intercourse and injection drug use.^[@B5]^ Moreover, between 2000 and 2011, the RR for anal cancer in black patients \<30 years old was reported to be 4.56 when compared with non-Hispanic white patients of similar age.^[@B6]^

Black race has also been consistently reported as a poor prognostic factor for the survival of anal cancer patients. Between 1973 and 2000, 5-year relative survival in black men decreased from 45% to 27%, whereas survival rates increased for white men and women.^[@B2]^ Multivariate analysis of anal cancer cases between 1973 and 2012 identified black race as being an independent predictor of lower survival.^[@B7],[@B8]^ Yet, the effect of socioeconomic status was not evaluated in these studies. The rising incidence of SCCA in the young male population, coupled with decreased survival in black men, raises significant concern for this population. It is necessary to identify any associated social factors that could be responsible for this racial disparity, to optimize outreach efforts. The aim of this study is to determine the effect of socioeconomic variables such as median family income and rural--urban continuum on incidence and survival in young men, as they are disproportionately at risk for SCCA. Further understanding of these variables will allow for better delineation of those most at risk, allowing for improved medical education outreach. Data from the Surveillance, Epidemiology and End Results (SEER) database will be analyzed to address this hypothesis.

Methods {#s002}
=======

After exemption from institutional review board approval was obtained, the SEER data set was queried for male patients, 18--49 years old, with histologically confirmed SCCA as their only cancer diagnosis between the years of 2000 and 2013, chosen to best correspond to census data on median family income. Cases were excluded if race was unknown, disease was unstaged, microscopic confirmation was not present, or if they were not actively followed in the database. Anal cancer was defined using the International Classification of Diseases for Oncology version 3 (ICD-0-3) site codes C21.0, C21.1, and C21.8. Squamous cell carcinoma was defined by SEER histology codes 8070--8078. Stage was defined using SEER definitions of *in situ*, localized, regional, and distant disease.

Incidence rates were standardized to the 2000 U.S. standard population. RR was calculated using incidence rate ratios. Cumulative expected survival rates were calculated using the Ederer II method, and relative age standardized survival rates were calculated using the actuarial method. Stage was evaluated according to the SEER-defined staging variable: summary stage 2000 (1998+). Median family income was determined on a county attribute level, based on data obtained from the Census American Community Survey 5-year files. Rural--urban category was determined using the United States Department of Agriculture Rural-Urban continuum codes. SEER\*Stat version 8.3.4 and SPSS version 24.0.0.0 were used for Mann--Whitney *U* tests, Cox Proportional Hazards Survival functions using 95% confidence intervals (CI), and *p* values of 0.05 to determine statistical significance.

Results {#s003}
=======

A total of 28,420 cases of cancer located in the anus, anal canal, and anorectum between 2000 and 2013 were identified in the SEER database. Of these, 21,425 were microscopically confirmed squamous cell carcinoma according to histology codes and 10,963 cases were men. Of these men, 5209 were \<50 years old, and after excluding cases of unknown race and stage, 4679 men were identified with SCCA between 2000 and 2013. In the final sample, 78.5% of patients were white, 18.0% were black, and 65.5% of cases were men aged 40--49 years. The incidence in black men aged 35--49 years was 4.393 compared with 3.136 in white men (*p*\<0.001), representing a rate ratio of 1.401. The incidence in black men \<35 years was 0.505 compared with 0.246 in white men (*p*\<0.001), representing a rate ratio of 2.052. On presentation, black men had more advanced disease than white men. Incidence rates by stage and rate ratios with respect to race are presented in [Table 1](#T1){ref-type="table"}. The incidence of *in situ* disease in patients residing in metropolitan areas was nearly four times higher than that of any other stage or residential location ([Table 2](#T2){ref-type="table"}).

###### 

**Incidence Rates and Rate Ratios of Squamous Cell Carcinoma of the Anus by Race, Stratified by Stage, in White and Black Males \<50 Years Old, 2000--2013**

              Black   White                         
  ----------- ------- ------- ------ ------- ------ ---------
  *In situ*   471     0.978   2564   0.827   1.18   0.001
  Localized   197     0.422   696    0.224   1.89   \<0.001
  Regional    137     0.293   334    0.107   2.73   \<0.001
  Distant     35      0.073   81     0.026   2.80   \<0.001

Rates are per 100,000 and age adjusted to the 2000 U.S. standard population.

###### 

**Incidence Rates of Squamous Cell Carcinoma of the Anus by Rural--Urban Continuum Stratified by Stage, in Males \<49 Years Old, 2000--2013**

  Rural--urban category       Stage       *N*     Rate           Confidence interval
  --------------------------- ----------- ------- -------------- ---------------------
  Metropolitan counties       *In situ*   3090    0.843          0.813--0.873
  Localized                   845         0.232   0.217--0.249   
  Regional                    458         0.126   0.114--0.138   
  Distant                     109         0.029   0.024--0.035   
  Non-Metropolitan counties   *In situ*   74      0.203          0.160--0.255
  Localized                   66          0.174   0.135--0.222   
  Regional                    25          0.067   0.044--0.100   
  Distant                     12          0.031   0.016--0.055   

Rates are per 100,000 and age-adjusted to the 2000 U.S. standard population.

The 5-year relative age standardized survival was significantly lower for black men \<50 years old (0.738, CI 0.696--0.776) than for white men (0.870, CI 0.855--0.884). Although there is a general decrease in survival with more progressive stages of disease, a significant racial disparity was identified among patients with *in situ* and localized disease. White men had significantly higher 5-year survival with *in situ* (0.954 vs. 0.892, *p*\<0.05) and localized disease (0.791 vs. 0.628, *p*\<0.05) than black men. White men in the highest two income quintiles had significantly improved 5-year survival across all stages than black men ([Fig. 1](#f1){ref-type="fig"}).

![Five-year age-standardized survival for males \<49 years old, with squamous cell carcinoma of the anus, 2000--2013, by median family income (\* denotes a statistically significant difference between white and black confidence intervals).](fig-1){#f1}

Based on the Cox Proportional Hazards model, black race was a poor prognostic factor for survival independent of stage, age, median family income, and rural--urban category ([Table 3](#T3){ref-type="table"}). Higher median family income was protective for survival, with each increase in median family income of \$10,000 associated with a 10% benefit to overall survival. Advanced stage significantly affected survival with localized, regional, and distant stages having significantly lower overall survival than *in situ* disease. Age and metropolitan residence did not significantly affect overall survival. The survival function curve based on the Cox regression model illustrates the significantly lower survival associated with black race when adjusted for median family income and stage ([Fig. 2](#f2){ref-type="fig"}).

![Cox regression survival function for race, adjusted for stage, and median family income.](fig-2){#f2}

###### 

**Cox Regression Model for Determinants of Survival in Male Patients \<50 Years Old with Squamous Cell Carcinoma of the Anus**

                                                         Hazard ratio   Confidence interval
  ------------------------------------------------------ -------------- ---------------------
  Race                                                                   
   White (ref)                                           1              ---
   Black                                                 1.556          1.332--1.817
  Stage                                                                 
   *In situ*                                             1              ---
   Localized                                             2.901          2.438--3.454
   Regional                                              5.572          4.648--6.678
   Distant                                               14.436         11.182--18.636
  Median family income^[a](#tf3){ref-type="table-fn"}^   0.901          0.862--0.943
  Age                                                    1.056          0.993--1.123
  Rural--urban^[b](#tf4){ref-type="table-fn"}^           1.061          0.789--1.426

Median family income variable was defined by increments of \$10,000.

Rural--urban category compares hazard ratio of cases in nonmetropolitan counties with those in metropolitan counties.

Discussion {#s004}
==========

The data demonstrate increased incidence of later stage disease in SCCA among black men than among white men, with nearly three times as many black men diagnosed with regional and distant disease at the time of presentation. Differences in the prevalence of HIV infection with respect to race is likely a major contributor to the racial disparity seen in the incidence of SCCA.^[@B5]^ Prior research indicates that elevated HIV rates among black MSM can be explained by high rates of undiagnosed seropositivity, high rates of sexually transmitted infections, low use of antiretroviral therapy (ART), and low adherence to ART.^[@B9]^ These factors likely apply to the incidence patterns observed here in SCCA. The CDC identifies inadequate HIV prevention education and interventions, limited awareness of infection, low perception of risk, alcohol and illegal drug use, and feelings of rejection and isolation as factors that may be contributing to the increased burden of HIV infection in this population.^[@B10]^ As HIV and SCCA are intimately related, addressing these factors through culturally sensitive education would likely decrease SCCA incidence.

We observed significantly higher incidence of overall disease, as well as a large shift toward diagnosis at earlier stages in metropolitan counties than nonmetropolitan counties. Similarly, McKenney et al. have shown decreased incidence of HIV in MSM in rural areas but worse outcomes. They attribute this to the lack of culturally appropriate outreach and prevention.^[@B11]^ A recent study of 1907 men (901 HIV+) from four major metropolitan areas identified a number of factors significantly associated with increased intention to seek screening. These factors included any history of anal condyloma, awareness of available screening in the community, current possession of health insurance, or current HIV infection.^[@B12]^ Studies specifically evaluating the barriers to screening for anal cancer among MSM cite unique barriers such as a lack of awareness of the disease in the patient, as well as a lack of healthcare recommendations to screen. They suggest an emphasis on healthcare literacy among at-risk groups to empower them to prevent cancer, more training for healthcare professionals, specifically those who routinely treat at-risk patients, and the development of national guidelines to promote anal dysplasia screening.^[@B13]^

Improved education surrounding the use of the HPV vaccination would also serve to decrease incidence of SCCA. The HPV vaccine is recommended for all men up to age 21 years, and through age 26 years for MSM. Yet, actual vaccination rates are dismal ranging from 4.9% to 21% in ages 18--26 years. A key barrier to vaccination is the stigma surrounding asking for the vaccine, as youths feel it may identify them as promiscuous.^[@B14]^ Providers need to proactively address possible stigma to better educate their patients on the benefits of vaccination. This would serve to improve vaccination rates, thereby decreasing incidence of SCCA.

Yet, incidence is only half of the battle. The significant racial disparity in survival between young men in this study was independent of county level income and stage of diagnosis. After adjustment for stage and median family income, black men continued to have lower survival than white men. Although many studies have identified treatment interventions that work in black MSM with HIV, very few have analyzed why outreach to black MSM with HIV tends to fall short.^[@B15]^ It is reasonable to assume that similar limitations apply when treating SCCA in black MSM, which would explain the lower observed survival seen in the regression analysis. Willeford et al. have noted significantly less follow-up with young black men, which is associated with higher rates of high-grade anal dysplasia.^[@B16]^ Failure to follow up with SCCA would also lead to lower survival.

Structural barriers, including stigma, racism, incarceration, and other barriers to care, have a significant impact on black men seeking healthcare.^[@B17]^ These barriers have been studied extensively in the realm of HIV treatment, and the conclusions are directly attributable to the health disparity in SCCA. Addressing the stigma surrounding MSM and anal health, in general, would serve to improve survival. Many young men feel stigmatized about their sexual practices, and anal health, in general, which lends to avoidance of the healthcare system.^[@B18]^ Community outreach programs would lead to earlier diagnosis and improved survival in SCCA, as was seen in the San Francisco SEER registry after implementation of new screening programs.^[@B5]^ Further research on the comparative effectiveness of culturally specific screening and health educational programs with respect to anal health would further improve outcomes in SCCA.

The limitations of this study include the inability to determine HIV status of individual patients within the SEER database, therefore, the effect of HIV prevalence on incidence and survival cannot be analyzed. Second, insurance status is not available in the SEER database, which may affect the likelihood of a patient to seek medical care. Third, income and geographic location are generalized to counties, and do not equally affect all patients living within that county. This limits the direct implication of county-level income on individual mortality. However, county income inequality is a significant determinant of health and controlling for it in regression analysis lends power to other factors such as race, and allows for the development of health improvement strategies that are applicable across the United States.^[@B19]^

Conclusions {#s005}
===========

Black race remains a poor prognostic indicator of survival of SCCA, even after controlling for median family income and stage. The health inequity identified here for diagnosis and treatment of SCCA likely parallels that studied for HIV, and using similar approaches to address this would greatly improve incidence and survival in SCCA.

Improved screening protocols would identify SCCA at earlier stages and improve overall survival in at-risk populations. We advocate for an expansion of screening protocols across the United States, with an emphasis on at-risk populations across all races. But, special emphasis should be placed on developing culturally sensitive programs designed for young black men, as this was shown to be a poor prognostic indicator. Patients will further benefit from proactive physicians who openly talk about anal health, HPV vaccination, and regular screening to create a safe space in their clinics for all patients.

Acknowledgments {#s006}
===============

The authors contributed to this study as follows: study conception and design were done by J.L.P., M.M.B., and R.J.K., acquisition of data was carried out by M.M.B., R.J.K., and J.L.P., analysis and interpretation of data were carried out by J.L.P., M.M.B., and R.J.K., drafting of article and critical revisions were done by J.L.P., M.M.B., and R.J.K. This study was presented by M.M.B. as a podium presentation at the 12th annual Academic Surgical Congress of the Association of Academic Surgery on February 9th, 2017, in Las Vegas, Nevada. This study used the SEER database. The interpretation and reporting of these data were the sole responsibilities of the authors. The authors acknowledge the efforts of the Applied Research program, NCI, and the SEER Program tumor registries in the creation of the SEER database.

Author Disclosure Statement {#s007}
===========================

No competing financial interests exist.

ART

:   antiretroviral therapy

CI

:   confidence interval

HIV

:   human immunodeficiency virus

HPV

:   human papillomavirus

RR

:   relative risk

SCCA

:   squamous cell carcinoma of the anus

SEER

:   surveillance, epidemiology, and end results

 {#s008}

**Cite this article as:** Bojko MM, Kucejko RJ, Poggio JL (2018) Racial disparities and the effect of county level income on the incidence and survival of young men with anal cancer, *Health Equity* 2:1, 193--198, DOI: 10.1089/heq.2018.0018.
